{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:14:00Z","timestamp":1771942440424,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier","isbn-type":[{"value":"9780128155578","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.apcsb.2018.10.009","type":"book-chapter","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T14:30:19Z","timestamp":1545143419000},"page":"341-407","source":"Crossref","is-referenced-by-count":13,"title":["Computational and modeling approaches to understand the impact of the Fabry's disease causing mutation (D92Y) on the interaction with pharmacological chaperone 1-deoxygalactonojirimycin (DGJ)"],"prefix":"10.1016","author":[{"given":"D.","family":"Thirumal Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Judith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Priyadharshini Christy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Siva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iftikhar Aslam","family":"Tayubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiranjib","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"George Priya Doss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.apcsb.2018.10.009_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.10.009_bb0015","doi-asserted-by":"crossref","first-page":"7.20.1","DOI":"10.1002\/0471142905.hg0720s76","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","volume":"76","author":"Adzhubei","year":"2013","journal-title":"Current Protocols in Human Genetics"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.10.009_bb0020","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s11011-018-0251-1","article-title":"Computational insights of K1444N substitution in GAP-related domain of NF1 gene associated with neurofibromatosis type 1 disease: A molecular modeling and dynamics approach","volume":"33","author":"Agrahari","year":"2018","journal-title":"Metabolic Brain Disease"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.10.009_bb0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11011-017-0121-2","article-title":"A profound computational study to prioritize the disease-causing mutations in PRPS1 gene","volume":"33","author":"Agrahari","year":"2018","journal-title":"Metabolic Brain Disease"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.10.009_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003440","article-title":"PredictSNP: Robust and accurate consensus classifier for prediction of disease-related mutations","volume":"10","author":"Bendl","year":"2014","journal-title":"PLoS Computational Biology"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.10.009_bb0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10545-009-1077-0","article-title":"The pharmacological chaperone 1-deoxygalactonojirimycin increases \u03b1-galactosidase A levels in Fabry patient cell lines","volume":"32","author":"Benjamin","year":"2009","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"13","key":"10.1016\/bs.apcsb.2018.10.009_bb0040","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1073\/pnas.83.13.4859","article-title":"Human alpha-galactosidase A: Nucleotide sequence of a cDNA clone encoding the mature enzyme","volume":"83","author":"Bishop","year":"1986","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/bs.apcsb.2018.10.009_bb0045","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1073\/pnas.85.11.3903","article-title":"Structural organization of the human alpha-galactosidase a gene: Further evidence for the absence of a 3\u2032 untranslated region","volume":"85","author":"Bishop","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.10.009_bb0050","doi-asserted-by":"crossref","first-page":"40065","DOI":"10.1038\/srep40065","article-title":"Two-step amyloid aggregation: Sequential lag phase intermediates","volume":"7","author":"Castello","year":"2017","journal-title":"Scientific Reports"},{"issue":"Suppl. 2","key":"10.1016\/bs.apcsb.2018.10.009_bb0055","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2105-14-S4-S5","article-title":"iStable: Off-the-shelf predictor integration for predicting protein stability changes","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.10.009_bb0060","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3390\/ijms17122010","article-title":"The large phenotypic spectrum of Fabry disease requires graduated diagnosis and personalized therapy: A meta-analysis can help to differentiate missense mutations","volume":"17","author":"Citro","year":"2016","journal-title":"International Journal of Molecular Sciences"},{"issue":"Database issue","key":"10.1016\/bs.apcsb.2018.10.009_bb0065","doi-asserted-by":"crossref","first-page":"D935","DOI":"10.1093\/nar\/gkr996","article-title":"SNPeffect 4.0: On-line prediction of molecular and structural effects of protein-coding variants","volume":"40","author":"De Baets","year":"2012","journal-title":"Nucleic Acids Research"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.10.009_bb0070","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jpeds.2004.01.051","article-title":"Fabry disease in childhood","volume":"144","author":"Desnick","year":"2004","journal-title":"The Journal of Pediatrics"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.10.009_bb0075","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/bs.apcsb.2018.10.009_bb0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1423-0127-16-42","article-title":"Investigation on the role of nsSNPs in HNPCC genes\u2014A bioinformatics approach","volume":"16","author":"Doss","year":"2009","journal-title":"Journal of Biomedical Science"},{"issue":"19","key":"10.1016\/bs.apcsb.2018.10.009_bb0085","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1111\/j.1742-4658.2007.06041.x","article-title":"Active-site-specific chaperone therapy for Fabry disease","volume":"274","author":"Fan","year":"2007","journal-title":"FEBS Journal"},{"issue":"2","key":"10.1016\/bs.apcsb.2018.10.009_bb0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","article-title":"The molecular defect leading to Fabry disease: Structure of human \u03b1-galactosidase","volume":"337","author":"Garman","year":"2004","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/bs.apcsb.2018.10.009_bb0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/B978-0-12-800168-4.00010-X","article-title":"Computational approaches and resources in single amino acid substitutions analysis toward clinical research","volume":"94","author":"George Priya Doss","year":"2014","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.10.009_bb0100","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s11011-017-0090-5","article-title":"Comparative computational assessment of the pathogenicity of mutations in the aspartoacylase enzyme","volume":"32","author":"George Priya Doss","year":"2017","journal-title":"Metabolic Brain Disease"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.10.009_bb0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1074-5521(97)90069-7","article-title":"Understanding enzymic catalysis: The importance of short, strong hydrogen bonds","volume":"4","author":"Gerlt","year":"1997","journal-title":"Chemistry & Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.10.009_bb0110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"15","key":"10.1016\/bs.apcsb.2018.10.009_bb0115","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-Pdb viewer: An environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.10.009_bb0120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/omi.2009.0045","article-title":"MetaPocket: A meta approach to improve protein ligand binding site prediction","volume":"13","author":"Huang","year":"2009","journal-title":"OMICS: A Journal of Integrative Biology"},{"issue":"8","key":"10.1016\/bs.apcsb.2018.10.009_bb0125","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/jhg.2013.48","article-title":"Newborn screening for Fabry disease in Japan: Prevalence and genotypes of Fabry disease in a pilot study","volume":"58","author":"Inoue","year":"2013","journal-title":"Journal of Human Genetics"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.10.009_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2183\/pjab.88.18","article-title":"Pharmacological chaperone therapy for Fabry disease","volume":"88","author":"Ishii","year":"2012","journal-title":"Proceedings of the Japan Academy, Series B"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.10.009_bb0135","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/ol100037c","article-title":"Short and straightforward synthesis of (\u2212)-1-deoxygalactonojirimycin","volume":"12","author":"Karjalainen","year":"2010","journal-title":"Organic Letters"},{"key":"10.1016\/bs.apcsb.2018.10.009_bb0140","first-page":"30","article-title":"The gene encoding alpha-galactosidase A and gene rearrangements causing Fabry disease","volume":"102","author":"Kornreich","year":"1989","journal-title":"Transactions of the Association of American Physicians"},{"key":"10.1016\/bs.apcsb.2018.10.009_bb0145","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/bs.apcsb.2015.09.008","article-title":"Investigating the inhibitory effect of Wortmannin in the hotspot mutation at codon 1047 of PIK3CA kinase domain: A molecular docking and molecular dynamics approach","volume":"102","author":"Kumar","year":"2016","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.10.009_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180581","article-title":"Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy","volume":"12","author":"Liguori","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.10.009_bb0155","first-page":"701","article-title":"Radius of gyration is indicator of compactness of protein structure","volume":"42","author":"Lobanov","year":"2008","journal-title":"Molekuliarnaia biologiia"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.10.009_bb0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/humu.22910","article-title":"Functional and clinical consequences of novel \u03b1-galactosidase a mutations in Fabry disease","volume":"37","author":"Lukas","year":"2015","journal-title":"Human Mutation"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.10.009_bb0165","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1021\/ct200196m","article-title":"An automated force field topology builder (ATB) and repository: Version 1.0","volume":"7","author":"Malde","year":"2011","journal-title":"Journal of Chemical Theory and Computation"},{"issue":"16","key":"10.1016\/bs.apcsb.2018.10.009_bb0170","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"Journal of Computational Chemistry"},{"issue":"13","key":"10.1016\/bs.apcsb.2018.10.009_bb0175","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/jcc.20090","article-title":"A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6","volume":"25","author":"Oostenbrink","year":"2004","journal-title":"Journal of Computational Chemistry"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.10.009_bb0180","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/hmat.1996.2146","article-title":"The origin of the method of steepest descent","volume":"24","author":"Petrova","year":"1997","journal-title":"Historia Mathematica"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.10.009_bb0185","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ygeno.2007.07.004","article-title":"Identification and in silico analysis of functional SNPs of the BRCA1 gene","volume":"90","author":"Rajasekaran","year":"2007","journal-title":"Genomics"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.10.009_bb0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1479-7364-2-5-297","article-title":"Fabry disease: Identification of 50 novel \u03b1-galactosidase a mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations","volume":"2","author":"Shabbeer","year":"2006","journal-title":"Human Genomics"},{"key":"10.1016\/bs.apcsb.2018.10.009_bb0195","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/TCRM.S11987","article-title":"Enzyme replacement therapy for Fabry disease: Some answers but more questions","volume":"7","author":"Sirrs","year":"2011","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"9","key":"10.1016\/bs.apcsb.2018.10.009_bb0200","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1002\/jcb.27097","article-title":"Structural analysis of missense mutations in galactokinase 1 (GALK1) leading to galactosemia type-2","volume":"119","author":"Sneha","year":"2018","journal-title":"Journal of Cellular Biochemistry"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.10.009_bb0205","article-title":"Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach","volume":"12","author":"Sneha","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.10.009_bb0210","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/jcb.25920","article-title":"Structural analysis of G1691S variant in the human filamin B gene responsible for Larsen syndrome: A comparative computational approach","volume":"118","author":"Sneha","year":"2017","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.apcsb.2018.10.009_bb0215","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s11011-018-0285-4","article-title":"Impact of missense mutations in survival motor neuron protein (SMN1) leading to spinal muscular atrophy (SMA): A computational approach","volume":"33","author":"Sneha","year":"2018","journal-title":"Metabolic Brain Disease"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.10.009_bb0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/07391102.2015.1007483","article-title":"Deciphering the impact of somatic mutations in exon 20 and exon 9 of PIK3CA gene in breast tumors among Indian women through molecular dynamics approach","volume":"34","author":"Sudhakar","year":"2015","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"10.1016\/bs.apcsb.2018.10.009_bb0225","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s11011-018-0286-3","article-title":"Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson's and Gaucher diseases","volume":"33","author":"Thirumal Kumar","year":"2018","journal-title":"Metabolic Brain Disease"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.10.009_bb0230","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/07391102.2016.1166456","article-title":"Influence of V54M mutation in giant muscle protein titin: A computational screening and molecular dynamics approach","volume":"35","author":"Thirumal Kumar","year":"2016","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"10.1016\/bs.apcsb.2018.10.009_bb0235","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s11011-018-0278-3","article-title":"Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2","volume":"33","author":"Thirumal Kumar","year":"2018","journal-title":"Metabolic Brain Disease"},{"issue":"11","key":"10.1016\/bs.apcsb.2018.10.009_bb0240","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1002\/jcb.26064","article-title":"A molecular docking and dynamics approach to screen potent inhibitors against fosfomycin resistant enzyme in clinical Klebsiella pneumoniae","volume":"118","author":"Thirumal Kumar","year":"2017","journal-title":"Journal of Cellular Biochemistry"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.10.009_bb0245","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney International"},{"key":"10.1016\/bs.apcsb.2018.10.009_bb0250","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jgar.2017.06.014","article-title":"Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid","volume":"11","author":"Unissa","year":"2017","journal-title":"Journal of Global Antimicrobial Resistance"},{"key":"10.1016\/bs.apcsb.2018.10.009_bb0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"Wang","year":"2007","journal-title":"Genetics in Medicine"},{"issue":"16","key":"10.1016\/bs.apcsb.2018.10.009_bb0260","first-page":"3105","article-title":"Genotype-phenotype correlation in patients with isovaleric acidaemia: Comparative structural modelling and computational analysis of novel variants","volume":"26","author":"Zaki","year":"2017","journal-title":"Human Molecular Genetics"},{"issue":"9647","key":"10.1016\/bs.apcsb.2018.10.009_bb0265","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"The Lancet"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Molecular Chaperones in Human Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162318300713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162318300713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T04:07:31Z","timestamp":1547006851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162318300713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128155578"],"references-count":52,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2018.10.009","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}